Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by HomerAndCompany


T.PRN

RE:Good week so far, hopefully earnings will help

Revenue was up two thirds over the same quarter in 2023, despite some...

7 days ago

T.PRN

RE:Up around 10% today - any idea why?

With the benefit of hindsight it seems likely that the 10% rise in share...

October 16, 2024

T.PRN

Fourth Quarter and Full Year 2023 Financial Results

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ...

March 8, 2024

T.NWH.DB.G

RE:$4.64

This steep drop in the SP coincided a sudden reversal in the interest rate...

February 7, 2024

T.NWH.DB.G

Fed's Rate Decision & Policy Statement - Good & Bad News

Bad news from decision - unlikely to cut interest rates at the next meeting...

February 1, 2024

T.PRN

RE:RE:insider buys

It surprises me that the public offering of Dec 27, 2023 was not priced...

December 29, 2023

T.PRN

Q1 2023 Financial Results - Recurring revenue up 43% YOY

..... Summary First Quarter 2023 Results For the quarter ended March 31...

May 11, 2023

T.PRN

Keytruda fails more prostate and lung cancer PhIII trials

ENDPOINTSNEWS Feb 28: Merck's Keytruda fails more prostate trials:

March 17, 2023

T.PRN

On cusp of exponential growth with 5% mo-over-mo rev growth?

2022 ended with 5% month-over-month revenue growth, that the company claims...

March 17, 2023

T.PRN

@2022 end 5% month-over-month revenue increase from 35 sites

Latest quarter 2022 was all about growing recurring revenue with TULSA-PRO...

March 9, 2023

T.PRN

Profound Medical Announces Q4 and Full Year 2022 Financials

................ "Our U.S. TULSA business, both in terms of installed...

March 8, 2023

T.PRN

RE:RE:RE:Concerns over new ways to fight cancer

The share price was more than halved within 2 months of the Sept 2 press...

November 25, 2022

T.PRN

Q3 Financial Results Webcast, Nov 3, 2022:30 sites in US now

30 sites in the US now, and they say that they're on track for 35 sites...

November 14, 2022

T.PRN

RE:Concerns over new ways to fight cancer

From what I've read the use of mRNA to treat cancer is something that has...

November 8, 2022

T.PRN

RE:RE:if you build it they will come

Q4 revenue double Q2? That's well into exponential growth teritory &...

August 12, 2022

T.ARIS

GCM now trading at a premium to ARIS based on 2-to-1 merger

I think this is the first time GCM has been at a premium to ARIS since the...

August 12, 2022

V.TLT

RE:Looking like the pharmer has a cyrstal ball

Looking like the pharmer has a stopped clock. It looks right for a few...

April 29, 2022

T.BCT

RE:BCTX Fast Track FDA Approval

Sell off on great news after a run-up on no news!? What's going on? -TIA ...

April 14, 2022

V.TLT

Big "Pending CR" & "Evaluable Patients" number tell us that

the ultrasound looks good, but it still takes 9 months to make a baby (no...

April 6, 2022

V.TLT

RE:RE:Still Early

Johnandrose22 wrote: Just a word of appreciation to those on the board who...

April 6, 2022

Featured Company